ArticlePharmaceutics2026

Unlocking the Potential of Population Pharmacokinetic Models of Adalimumab in Patients with Crohn's Disease.

Marija Jovanović et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.